Subtype-specific autophagy profiles in Renal Cell Carcinoma

Autophagy is a highly conserved cellular mechanism essential for recycling intracellular components and providing energy and maintaining cellular homeostasis. The role of autophagy in cancer is double sided, where it can suppress tumorigenesis by degrading damaged organelles and preventing chronic inflammation while supporting survival of existing tumor cells to survive during starvation and stress, and thus support tumor growth. The role of autophagy in renal cell carcinoma (RCC), the most common type of kidney cancer, remains insufficiently described. RCC originates from epithelial cells of the renal tubule and is divided into histological subtypes where clear cell RCC is the most common followed by papillary and chromophobe RCC, showing differences in morphology and molecular features. Recent studies of RCC suggest that mTORC1 and autophagy are involved in kidney cancer development and response to treatment, advocating the need to better understand the role of autophagy in RCC. To this end, we investigated autophagy markers by immunostaining, immunoblotting and quantitative PCR in biobanked fresh-frozen tissue samples of RCC tumor and matched normal tissue. Overall, we found reduced levels of LC3B and GABARAPL1 in clear cell RCC, in stark contrast to chromophobe RCC and benign oncocytoma. This suggests that autophagy levels differ between renal tumor subtypes, indicating that autophagy could play subtype-specific roles. In addition, autophagy modulating drug assays demonstrated autophagy dependencies in metastatic RCC cell line spheroids. This could provide new inroads for therapeutical approaches in RCC.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.17.767069
Primary Topic
Autophagy in Disease and Therapy
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Subtype-specific autophagy profiles in Renal Cell Carcinoma

Stig Müller, Karol Axcrona, Julie Aarmo Johannessen, Helene Knævelsrud et al.
bioRxiv (Cold Spring Harbor Laboratory)
Autophagy in Disease and Therapy
preprint

Subtype-specific autophagy profiles in Renal Cell Carcinoma

Stig Müller, Karol Axcrona, Julie Aarmo Johannessen, Helene Knævelsrud, Frode S. Nilsen, Manuela Zucknick, Jorrit M. Enserink, Leiv Rønneberg, Siri Andresen, Lóránt Farkas, Eva Bassols‐Citores, Feyza Kasikci, Maria Frison, Elise Komttebed
preprint en

Abstract

Autophagy is a highly conserved cellular mechanism essential for recycling intracellular components and providing energy and maintaining cellular homeostasis. The role of autophagy in cancer is double sided, where it can suppress tumorigenesis by degrading damaged organelles and preventing chronic inflammation while supporting survival of existing tumor cells to survive during starvation and stress, and thus support tumor growth. The role of autophagy in renal cell carcinoma (RCC), the most common type of kidney cancer, remains insufficiently described. RCC originates from epithelial cells of the renal tubule and is divided into histological subtypes where clear cell RCC is the most common followed by papillary and chromophobe RCC, showing differences in morphology and molecular features. Recent studies of RCC suggest that mTORC1 and autophagy are involved in kidney cancer development and response to treatment, advocating the need to better understand the role of autophagy in RCC. To this end, we investigated autophagy markers by immunostaining, immunoblotting and quantitative PCR in biobanked fresh-frozen tissue samples of RCC tumor and matched normal tissue. Overall, we found reduced levels of LC3B and GABARAPL1 in clear cell RCC, in stark contrast to chromophobe RCC and benign oncocytoma. This suggests that autophagy levels differ between renal tumor subtypes, indicating that autophagy could play subtype-specific roles. In addition, autophagy modulating drug assays demonstrated autophagy dependencies in metastatic RCC cell line spheroids. This could provide new inroads for therapeutical approaches in RCC.

bioRxiv (Cold Spring Harbor Laboratory)
Oslo University Hospital (NO), University of Oslo (NO), Akershus University Hospital (NO)
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon